Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rodent reproductive tissues refer to the complex organ systems in mice and rats, such as the testes, ovaries, and uterus, which are central to reproductive biology and toxicology studies (OECD, 2018). These tissues are not classified as a single molecular target; rather, they are biological sites where various drugs and chemicals exert effects through specific receptors like the estrogen or androgen receptors (NIH, 2023). In pharmaceutical development, these tissues are primarily evaluated during safety pharmacology and toxicology assessments to identify risks of reproductive impairment or developmental toxicity (FDA, 2020). For instance, drugs like cyclophosphamide are known to cause damage to these tissues, leading to infertility in rodent models (PubMed, 2021). Consequently, while they are not therapeutic targets themselves, they are critical for monitoring the safety profile of new drug candidates and understanding the physiological impact of endocrine-disrupting chemicals.
Not applicable as this refers to a tissue system rather than a specific molecular target.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rodent reproductive tissues.